Blockbuster weight loss meds like Ozempic and Wegovy are now linked to a rare eye disease that can lead to blindness.

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

Explore the benefits of Mochi Health, a telehealth platform offering personalized weight loss solutions and support.

The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published ...

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

It's probably safe to say that weight-loss drugs aren't going anywhere any time soon. According to the most recent data, six percent of American adults, or roughly 16 million people, take such ...